Form 4: Envista Holdings CEO Paul Keel Reports Acquisition of Stock Options and Restricted Stock Units

Envista Holdings CEO Paul Keel reports the acquisition of stock options, restricted stock units (RSUs), and performance share units (PSUs) on May 25, 2024.

Summary

• On May 25, 2024, Paul A. Keel, CEO of Envista Holdings Corp, reported the acquisition of several non-derivative and derivative securities.
• Keel acquired 71,235 shares of common stock in the form of Restricted Stock Units (RSUs) that vest ratably over three years.
• He also acquired 301,370 shares of common stock in the form of RSUs that vest in three tranches on November 1, 2024, 2025, and 2026.
• Keel was granted options to buy 696,210 shares of Envista common stock at an exercise price of $18.25, vesting in three equal installments on November 1, 2024, 2025, and 2026, expiring on May 25, 2034.
• Additionally, he received options to buy 164,560 shares of Envista common stock at an exercise price of $18.25, vesting ratably over three years, expiring on May 25, 2034.
• Keel also acquired 205,265 Performance Share Units (PSUs) that will vest based on the achievement of performance measures over a three-year period ending December 31, 2026, with potential payout ranging from 0% to 200% of the target amount.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grants align management with shareholder interests, but the value is contingent on future performance.

Positives

• The grant of stock options and RSUs aligns the CEO's interests with those of the shareholders, incentivizing him to improve company performance.
• The vesting schedules of the RSUs and stock options encourage long-term commitment from the CEO.
• The Performance Share Units (PSUs) are tied to specific performance metrics, further aligning executive compensation with company goals.

Risks

• The value of the stock options and RSUs is dependent on the future performance of Envista Holdings Corp's stock price.
• The actual number of shares received from the Performance Share Units (PSUs) may be lower than the target amount if performance goals are not fully achieved.

Future Outlook

The vesting of the RSUs and stock options is contingent upon continued service, and the payout of the PSUs depends on the achievement of performance measures over a three-year period.

Industry Context

Stock option and RSU grants are common practices in executive compensation to align management's interests with those of shareholders in the dental and medical technology industry.

Comparison to Industry Standards

• Companies like Align Technology and Dentsply Sirona also use stock options and RSUs as part of their executive compensation packages.
• The vesting schedules and performance metrics associated with these grants are generally in line with industry standards for incentivizing long-term performance.

Stakeholder Impact

• Shareholders may view the grants positively as they align management's interests with long-term value creation.
• Employees may see the grants as a sign of confidence in the company's future prospects.

Next Steps

• The CEO will continue to hold the securities and potentially exercise the stock options as they vest.
• The company will monitor the performance metrics associated with the PSUs to determine the final payout amount.

Key Dates